WELCOME TO SOBLAZE

NOLLYWOOD | ENTERTAINMENT | RELATIONSHIPS | HEALTH | WORLD NEWS

PROMOTE MUSIC | ADVERTISE | PRIVACY POLICY



.

FEATURED VIDEO THIS WEEK

Blogger Widgets
  • Monalisa Chinda's Foundation Partners With NAFDAC
  • The latest at the disposal is an overwhelming partnership between the Arise Monalisa Foundation [AMF] and National Agency for Food and Drug Administration and Control [NAFDAC] to unite together to further safeguard the health of Nigerian women.

    PR Team, Monalisa Chinda Inc reported that after eight years of supporting major autism campaign causes, funding education for the less priviledged, organizing charitable visits to orphanages and prisons amongst others, the Arise Monalisa Foundation has embarked on the Uterine Fibroid Project, this year, aimed at creating awareness, sensitizing the populace and sponsoring treatment of infected women across the country.

    The multi-award winning actress Monalisa Chinda the founder of the Arise Monalisa Foundation (AMF) made her speech during the course of the meeting which took place on Wednesday 14th January 2015 at NAFDAC's headquarters in Abuja. "It is in giving our lives away that we find meaning... We appreciate NAFDAC for this strategic partnership as we look forward to propagating awareness of this fast spreading yet widely neglected uterine fibroid, which has become very common among
    women due to ignorance and stigmatization."
     
    she said.

    Director General, NAFDAC, Dr. Paul Orhii, also speaks in regards of their partnership with the Arise Monalisa Foundation ,  "We are proud to partner with the Arise Monalisa Foundation in mobilizing this timely project throughout the six geo-political zones in Nigeria, and this also marks the flag-off of our projects for this year." He concluded.

    The Nollywood superstar Monalisa Chinda is set and poised to take her humanitarian dispositions to a greater height and has already started on a good note. More grease to her elbow.

    You might also like this.... CLICK HERE

    Related Posts:

    No comments:

    Post a Comment